Labor induction and meconium:: in vitro effects of oxytocin, dinoprostone and misoprostol on rat ileum relative to myometrium

被引:13
作者
Matonhodze, BB
Katsoulis, LC
Hofmeyr, GJ
机构
[1] Univ Witwatersrand, Sch Med, Dept Pharm & Pharmacol, ZA-2193 Johannesburg, South Africa
[2] Univ Witwatersrand, Effect Care Res Unit, ZA-2193 Johannesburg, South Africa
关键词
dinoprostone; labor induction; meconium; misoprostol; oxytocin; prostaglandin dehydrogenase;
D O I
10.1515/JPM.2002.063
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Background. Oxytocin and various prostaglandin preparations are commonly used for pharmacological induction of labor at term. Some prostaglandin preparations appear to be associated with more fetal meconium passage and maternal gastrointestinal side effects than is oxytocin. These adverse effects may be caused by stimulation of bowel smooth muscle in the mother and in the fetus. Aim. To determine whether the in vitro deal contractile activities of dinoprostone,misoprostol and oxytocin are in keeping with the variation in rates of meconium staining observed during labor induction with these substances. Methods. The contractile activity of the drugs was tested on isolated rat uterus and ileum mounted in Tyrode's solution. Results. Uterine contractions were stimulated by all three drugs, whereas ileal contractions were only stimulated by dinoprostone and misoprostol. Oxytocin had no contractile activity on the ileum. Dinoprostone and misoprostol stimulated significantly (p < 0.05) larger uterine contractions than deal contractions. Conclusion. These results provide a pharmacological basis for the increased rate of maternal gastrointestinal complaints and meconium passage with labor induction using dinoprostone and misoprostol compared to oxytocin. Based on the above findings, we postulate that the difference in the rates of meconium passage following misoprostol and dinoprostone administration is caused by pharmacokinetic rather than pharmacodynamic differences between the two drugs.
引用
收藏
页码:405 / 410
页数:6
相关论文
共 29 条
[1]  
ALFIREVIC Z, 2000, COCHRANE LIB
[2]   Prostaglandin dehydrogenase and the initiation of labor [J].
Challis, JRG ;
Patel, FA ;
Pomini, F .
JOURNAL OF PERINATAL MEDICINE, 1999, 27 (01) :26-34
[3]   CHEMISTRY AND SYNTHETIC DEVELOPMENT OF MISOPROSTOL [J].
COLLINS, PW ;
PAPPO, R ;
DAJANI, EZ .
DIGESTIVE DISEASES AND SCIENCES, 1985, 30 (11) :S114-S117
[4]   Misoprostol therapeutics revisited [J].
Davies, NM ;
Longstreth, J ;
Jamali, F .
PHARMACOTHERAPY, 2001, 21 (01) :60-73
[5]   FATAL MECONIUM ASPIRATION SYNDROME OCCURRING DESPITE AIRWAY MANAGEMENT CONSIDERED APPROPRIATE [J].
DAVIS, RO ;
PHILIPS, JB ;
HARRIS, BA ;
WILSON, ER ;
HUDDLESTON, JF .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1985, 151 (06) :731-736
[6]   Manufacturer's warning regarding unapproved uses of misoprostol. [J].
Friedman, MA .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (01) :61-61
[7]   Drug therapy: Misoprostol and pregnancy. [J].
Goldberg, AB ;
Greenberg, MB ;
Darney, PD .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (01) :38-47
[8]   Use of misoprostol in pregnancy. [J].
Hale, RW ;
Zinberg, S .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (01) :59-60
[9]  
HOFMEYER GJ, 1993, S AFR MED J, V83, P739
[10]   Misoprostol for induction of labour:: a systematic review [J].
Hofmeyr, GJ ;
Gülmezoglu, AM ;
Alfirevic, Z .
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1999, 106 (08) :798-803